Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes

J Diabetes Investig. 2023 Aug;14(8):1009-1010. doi: 10.1111/jdi.14030. Epub 2023 May 29.

Abstract

Serum fibroblast growth factor 21 levels in patients with mitochondrial diabetes might be much higher than in those with other diabetes types. The results of this study could lead to the establishment of a simple method for screening mitochondrial diabetes using peripheral blood serum.

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • Diabetes Mellitus, Type 2*
  • Fibroblast Growth Factors*
  • Humans

Substances

  • fibroblast growth factor 21
  • Biomarkers
  • Fibroblast Growth Factors